UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

Benzinga Newsdesk www.benzinga.com Neutral 73.4%

Neg 0% Neu 73.4% Pos 0%

UBS analyst Ryan Gravett initiates coverage on Core Scientific (NASDAQ:CORZ) with a Buy rating and announces Price Target of $24.